242 related articles for article (PubMed ID: 29395486)
41. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
[TBL] [Abstract][Full Text] [Related]
42. Targeted Next Generation Sequencing Revealed Novel Variants in the
Hosseinpour M; Ardalani F; Mohseni M; Beheshtian M; Arzhangi S; Ossareh S; Najmabadi H; Nobakht A; Kahrizi K; Broumand B
Arch Iran Med; 2022 Sep; 25(9):600-608. PubMed ID: 37543885
[TBL] [Abstract][Full Text] [Related]
43. [Genetic analysis (PKD2) of autosomal dominant polycystic kidney disease].
Gómez PF; Moro EC; García-Cosmes P; Sarmiento RG; Romo JM
Nefrologia; 2009; 29(6):562-8. PubMed ID: 19936001
[TBL] [Abstract][Full Text] [Related]
44. Genotype-Clinical Correlations in Polycystic Kidney Disease with No Apparent Family History.
Sekine A; Fujimaru T; Hoshino J; Suwabe T; Oguro M; Mizuno H; Kawada M; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Mandai S; Chiga M; Kikuchi H; Ando F; Mori T; Sohara E; Uchida S; Sawa N; Takaichi K; Ubara Y
Am J Nephrol; 2019; 49(3):233-240. PubMed ID: 30820006
[TBL] [Abstract][Full Text] [Related]
45. Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System.
Kinoshita M; Higashihara E; Kawano H; Higashiyama R; Koga D; Fukui T; Gondo N; Oka T; Kawahara K; Rigo K; Hague T; Katsuragi K; Sudo K; Takeshi M; Horie S; Nutahara K
PLoS One; 2016; 11(11):e0166288. PubMed ID: 27835667
[TBL] [Abstract][Full Text] [Related]
46. Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease.
Obeidova L; Elisakova V; Stekrova J; Reiterova J; Merta M; Tesar V; Losan F; Kohoutova M
BMC Med Genet; 2014 Apr; 15():41. PubMed ID: 24694054
[TBL] [Abstract][Full Text] [Related]
47. Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
Tsilosani A; Gao C; Chen E; Lightle AR; Shehzad S; Sharma M; Tran PV; Bates CM; Wallace DP; Zhang W
J Am Soc Nephrol; 2024 Apr; 35(4):398-409. PubMed ID: 38254271
[TBL] [Abstract][Full Text] [Related]
48. Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease.
Liu B; Chen SC; Yang YM; Yan K; Qian YQ; Zhang JY; Hu YT; Dong MY; Jin F; Huang HF; Xu CM
Sci Rep; 2015 Dec; 5():17468. PubMed ID: 26632257
[TBL] [Abstract][Full Text] [Related]
49. Novel PKD1 Mutations in Patients with Autosomal Dominant Polycystic Kidney Disease.
Kim H; Kim HH; Chang CL; Song SH; Kim N
Lab Med; 2021 Mar; 52(2):174-180. PubMed ID: 32816041
[TBL] [Abstract][Full Text] [Related]
50. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
Senum SR; Li YSM; Benson KA; Joli G; Olinger E; Lavu S; Madsen CD; Gregory AV; Neatu R; Kline TL; Audrézet MP; Outeda P; Nau CB; Meijer E; Ali H; Steinman TI; Mrug M; Phelan PJ; Watnick TJ; Peters DJM; Ong ACM; Conlon PJ; Perrone RD; Cornec-Le Gall E; Hogan MC; Torres VE; Sayer JA; ; Harris PC
Am J Hum Genet; 2022 Jan; 109(1):136-156. PubMed ID: 34890546
[TBL] [Abstract][Full Text] [Related]
51. Molecular diagnosis of autosomal dominant polycystic kidney disease.
Song X; Haghighi A; Iliuta IA; Pei Y
Expert Rev Mol Diagn; 2017 Oct; 17(10):885-895. PubMed ID: 28724316
[TBL] [Abstract][Full Text] [Related]
52. Coexistence of autosomal dominant polycystic kidney disease type 1 and hereditary renal hypouricemia type 2: A model of early-onset and fast cyst progression.
Peces R; Mena R; Peces C; Cuesta E; Selgas R; Barruz P; Lapunzina P; Nevado J
Clin Genet; 2020 Jun; 97(6):857-868. PubMed ID: 32166738
[TBL] [Abstract][Full Text] [Related]
53. PKD1-Associated Arachnoid Cysts in Autosomal Dominant Polycystic Kidney Disease.
Shigemori K; Higashihara E; Itoh M; Yoshida H; Yamamoto K; Nutahara K; Shiokawa Y; Kaname S; Tambo M; Yamaguchi T; Taguchi S; Yoshioka T; Yokoyama K; Fukuhara H
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105943. PubMed ID: 34175641
[TBL] [Abstract][Full Text] [Related]
54. Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
Wilk EJ; Howton TC; Fisher JL; Oza VH; Brownlee RT; McPherson KC; Cleary HL; Yoder BK; George JF; Mrug M; Lasseigne BN
Mol Med; 2023 May; 29(1):67. PubMed ID: 37217845
[TBL] [Abstract][Full Text] [Related]
55. Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.
Tan AY; Zhang T; Michaeel A; Blumenfeld J; Liu G; Zhang W; Zhang Z; Zhu Y; Rennert L; Martin C; Xiang J; Salvatore SP; Robinson BD; Kapur S; Donahue S; Bobb WO; Rennert H
J Am Soc Nephrol; 2018 Aug; 29(8):2139-2156. PubMed ID: 30042192
[TBL] [Abstract][Full Text] [Related]
56. Novel PKD1 and PKD2 mutations in Taiwanese patients with autosomal dominant polycystic kidney disease.
Chang MY; Chen HM; Jenq CC; Lee SY; Chen YM; Tian YC; Chen YC; Hung CC; Fang JT; Yang CW; Wu-Chou YH
J Hum Genet; 2013 Nov; 58(11):720-7. PubMed ID: 23985799
[TBL] [Abstract][Full Text] [Related]
57. Polycystic Kidney Disease without an Apparent Family History.
Iliuta IA; Kalatharan V; Wang K; Cornec-Le Gall E; Conklin J; Pourafkari M; Ting R; Chen C; Borgo AC; He N; Song X; Heyer CM; Senum SR; Hwang YH; Paterson AD; Harris PC; Khalili K; Pei Y
J Am Soc Nephrol; 2017 Sep; 28(9):2768-2776. PubMed ID: 28522688
[TBL] [Abstract][Full Text] [Related]
58. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
[TBL] [Abstract][Full Text] [Related]
59. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.
Audrézet MP; Cornec-Le Gall E; Chen JM; Redon S; Quéré I; Creff J; Bénech C; Maestri S; Le Meur Y; Férec C
Hum Mutat; 2012 Aug; 33(8):1239-50. PubMed ID: 22508176
[TBL] [Abstract][Full Text] [Related]
60. Autosomal dominant polycystic kidney disease (ADPKD) in Tunisia: From molecular genetics to the development of prognostic tools.
Abdelwahed M; Hilbert P; Ahmed A; Dey M; Bouomrani S; Kamoun H; Ammar-Keskes L; Belguith N
Gene; 2022 Apr; 817():146174. PubMed ID: 35031424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
